Hyun Sook An

Title: The Innovations of Hyun Sook An

Introduction

Hyun Sook An is a notable inventor based in Seongnam, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific cancer pathways. His work is crucial in the ongoing fight against cancer, providing new avenues for treatment.

Latest Patents

Hyun Sook An holds a patent for "Pyrimidinedione-based compounds as AXL, c-MET, and Mer inhibitors and methods of use thereof." This patent describes an inhibitor of AXL, Mer, and/or c-Met, which can be represented by a specific formula. The invention includes a method for treating or preventing diseases mediated by these targets, particularly in cases where cancer cells have developed resistance to existing anti-cancer agents.

Career Highlights

Throughout his career, Hyun Sook An has focused on innovative solutions in the pharmaceutical industry. His work has led to advancements in cancer treatment, showcasing his commitment to improving patient outcomes. He is currently associated with Cmg Pharmaceutical Co., Ltd., where he continues to develop groundbreaking therapies.

Collaborations

Hyun Sook An has collaborated with notable colleagues, including Jin Sung Kim and Young Sang Kim. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Hyun Sook An's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his innovative spirit and dedication to improving healthcare. His patent on pyrimidinedione-based compounds represents a significant advancement in the fight against cancer.